📢 A NEW #ISHLT Guideline Document for the evaluation and care of #HeartTransplant candidates is now available. 📖🫀 This document provides recommendations based on contemporary scientific evidence & patient management flow diagrams. Check out the top ten takeaways ⏬ and read

Excited for #ACCAsia to begin in Delhi, India ⁦Cathie Biga⁩ ⁦Christopher Kramer MD⁩ ⁦⁦Kwan S Lee⁩ ⁦American College of Cardiology⁩

Our paper: Prevalence, Cardiac Phenotype, and Outcomes of TTR Variants in the UK Biobank Population is now out JAMA Cardiology jamanetwork.com/journals/jamac… - a pleasure to lead this work with Nay Aung, in another great Barts Health UCL Institute of Cardiovascular Science William Harvey Research Institute collaboration. interesting data!

What is the relationship between lifestyle risk factors and #CVD risk factors in women with breast cancer? Read the latest journal scan on the Life’s Essential 8 score and CVD in survivors ➡️ bit.ly/478kn5u #cvPrev #CardioOnc

🚨­­ MAJOR news in the #ATTR #amyloidosis world! Today the ­­­much-anticipated HELIOS-B results were presented European Society of Cardiology & simultaneously published in NEJM. The largest ATTR-CM trial published to date, testing #vutrisiran vs. placebo. Bottom line: Huge win for vutrisiran!

🚨see Vivienne Sullivan excellent summary slides for key takeaways when initiating ATTR stabilizer therapy!

Dive into the world of cardiology at the Washington ACC Annual Meeting! Connect, learn & grow with healthcare leaders on Sept 14. Don’t miss out—register now: ow.ly/xoZ350SUbWs #WACC2024 #HealthcareNetworking #cardiotwitter

HLA allosensitization remains a barrier for heart transplant for many individuals despite desensitization. Heart after liver transplant with domino of the liver into another recipient may be an effective strategy for selected cases.

Notably, all patients in our series were women, who are less likely to be transplanted partly due to increased risk for allosensitization from pregnancies. Additionally, Black individuals are more likely to have higher cPRAs compared to other racial groups.

Submit an abstract to #ISHLT2025! 📝 ISHLT wants your best science in the treatment of advanced 🫀 + 🫁 disease, #transplantation, #MCS, & #PVD. Abstracts are being accepted in the following areas: ▶️ Research Abstracts ▶️ Early Career Clinical Case Reports ▶️ Late-Breaking

📢 #ISHLT endorses the 2024 Update to the 2020 American College of Cardiology/AHA Science Clinical Performance & Quality Measures for Adults w #HeartFailure. These performance measures are appropriate for public reporting or pay-for-performance programs. Read more:🔗 bit.ly/4dR1LJz